Dr. Parag Mehtani, MD

Dr. Mehtani practices at Fontana Dialysis in Fontana, California.

Dr. Mehtani's NPI, 1770773160, was assigned on July 31, 2007. Dr. Mehtani holds California license A100778.

Dr. Mehtani's primary practice is Fontana Dialysis, at 16655 Foothill Blvd, Fontana, CA 92335 in San Bernardino County. The practice phone is (909) 546-2012.

Dr. Mehtani's primary practice is Fontana Dialysis in Fontana, California. Dr. Mehtani is also affiliated with Redlands Community Hospital. The medical group on file is Nephrology Associates Medical Group. Dmand AI also links Dr. Mehtani to 4 more hospitals, 3 dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mehtani practices, 9 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Mehtani's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Mehtani is board certified in nephrology by the American Board of Internal Medicine. Dr. Mehtani is licensed in California.

Dmand AI lists chronic kidney disease among the conditions Dr. Mehtani treats.

CMS data shows 1,948 Medicare services from Dr. Mehtani across 10 procedure codes in 2024, for 349 Medicare patients. Medicare paid $155,594 for them.

CMS counts 349 Medicare patients who saw Dr. Mehtani in 2024. The largest group is 65 to 74, with 137 patients. 75% of them have chronic kidney disease, and 75% have diabetes. 70% are also on Medicaid. Their average risk score is 5.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mehtani's median patient age at 67, with 47% women.

In 2024, Dr. Mehtani wrote 1,538 Medicare Part D claims for 232 patients. 81% of them were for generic drugs. CMS names the drug for 1,357 of them, across 33 drugs with 11 or more claims each, at $290,091 in total drug cost. In 2023, CMS named 1,432 claims across 30 drugs.

Dr. Mehtani accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Mehtani, published from 2008 to 2014. 2014 was the busiest year, with 2. The most frequent topics are Vasoconstriction. Dr. Mehtani's most frequent co-authors are Maple M. Fung, MD, Michael G. Ziegler, MD and Sharon G. Adler, MD.

CMS Open Payments shows 551 general payments to Dr. Mehtani from 35 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 66% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $21,804.

Dr. Mehtani is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.